The Evaluation Complementary Spirit Therapy

NCT03356691 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2018-04-17

No results posted yet for this study

Summary

Background: Complementary Spiritist Therapy (ECT) based on a range of therapeutic resources including prayer, spiritist "passe", fluidotherapy (fluidic water or magnetized water), spirit education. The aim of this study was to evaluate the effects of ECT in individuals at UFTM Hospital de Clínicas.

Methods: Randomized controlled trial, patients were randomly. Patients will then be allocated into groups:

* The group submitted to ECT (prayer, spiritual education, spiritist "passe" and fluidized water or prayer or spiritist "passe" or laying on of hands with intent to heal or laying on of hands with intent to heal or fluidized water or no-fluidized water or Control group (CG) will not be submitted to any intervention.

Conditions

Interventions

OTHER

Complementary Spiritist Therapy

Complementary Spiritist Therapy: 1. Prayer: for 1 to 2 minutes. 2. Spiritual education: reading and commentary of the Gospel according to Spiritism, about 7 minutes. 3. Spiritist "passe, for 2-min. 4. Fluid therapy.

OTHER

Prayer

Individuals will receive prayer during 1 to 2 minutes.

OTHER

Spiritist "passe"

Individuals will receive Spiritist "passe" during 5 to 10 minutes.

OTHER

laying on of hands with intent to heal

Individuals will receive laying on of hands with intent to heal during 5 to 10 minutes.

OTHER

Fluid therapy.

Individuals will receive fluid therapy.

OTHER

No-fluid therapy.

Individuals will receive no-fluid therapy.

Sponsors & Collaborators

  • Universidade Federal do Triangulo Mineiro

    lead OTHER

Principal Investigators

  • Élida M Carneiro, PhD · Spiritist Medical Association of Uberaba

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-10
Primary Completion
2018-04-09
Completion
2025-12-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03356691 on ClinicalTrials.gov